SMC Laboratories, Inc

Solutions to Achieve your Drug Development Goals SMC is a pre-clinical CRO (Contract Research Organization) founded in 2014 with a mission to accelerate drug research and development through our focused fibrosis and inflammatory expertise. We have supported over 600 pharmaceutical companies, bio-ventures and academics from over 29 countries with our cutting-edge research and pharmacology studies using our mouse models specialized for inflammation and fibrosis, including liver disease (NASH, NAFLD, Cirrhosis, HCC, ALF), IPF, CKD, IBD, SSc and cancer. In particular, our unique NASH-HCC model (STAM model) is a mouse model with high clinical correlation - 15 compounds tested in the...

Hepatology,nash,nafld,non-clinical study,pharmacology,translational ,ipf,fibrosis,ibd,cro,gastrology,cancer,hepatocellular carcinoma,steatosis,inflammation,ckd,skin fibrosis,acute lung injury,liver disease,and copd

Smc laboratories, inc operates in the Biotechnology research industry.

Smc laboratories, inc's revenue is 11m - 100m

Smc laboratories, inc has 11 - 50 employees.